Studying the replication pattern of Human immunodeficiency virus (HIV) is essential to understand modalities that could halt its survival in-vivo. The CC chemokine receptor 5 (CCR5) is exploited by HIV to gain entry into CD4+ cells. There are several polymorphisms in CCR5; the major coreceptor of HIV that has major influence on HIV transmission and progression to acquired immunodeficiency syndrome (AIDS). CCR5 genes that code for the CCR5 differ in humans, some individuals acquire mutant form this gene with 32 base pair deletion through mendelian inheritance pattern. Individuals who are homozygous for this gene are completely resistant to HIV infection while heterozygous individuals had extended life span while being infected for an average of 2 to 3 years. CCR5∆32 allele is young in evolutionary time, yet it has reached relatively high frequencies in Caucasians but very low among native Africans. These properties indicate that the mutation has been under intense pressure selection. Surprisingly, there has not been any categorical explanation for this genetic selection. The absence or rare occurrence of CCR5 32 allele among native Africans may be an explanation for high HIV transmission rate and burden in this race. There are very limited CCR5Δ32 studies from Africa thus, justifies the need for researchers to embark on more CCR5Δ32 projects in order to establish full range of mutant CCR5 genes that may exist in our societies.
Introduction

Human immunodeficiency virus (HIV)
infection continues to be an expanding epidemic worldwide. The risk of HIV transmission varies and depends on multiple factors, in particular on the type of exposure: blood transfusions represent the greatest risk, with 90%, followed by vertical transmission with a 10-30% risk in the absence of any prophylactic intervention [1] . In contrast, the risk of transmission by sharing infectious needles is low, 1% similar to the 0.3% risk during accidental exposure in healthcare personnel [1] .
In [1] . [2] .
The CCR5 gene codes for a seven transmembrane protein similar to G protein-coupled chemokine receptor.
Chemokines and their receptors form regulatory networks that control the development, recruitment and activation of lymphocytes. Thus, chemokine receptors play a central role in the immune response against many pathogens, particularly during inflammatory response [3] . CCR5 is the ) a target in the treatment of HIV [3] .
It was almost simultaneous with the discovery of HIV coreceptors, a mutation in the gene that codifies for the CCR5 molecule which confers a high degree of resistance to HIV infection was also described [2, 3] . [2, 3] . The CCR5∆32 is estimated to be present in 15 to 20% of Caucasians individuals [3] however, other mutation in chemokine single nucleotide polymorphisms (SNIPs) have been more closely related to slow clinical progression than to resistance [4] . Intriguely, CCR5∆32 allele is young in evolutionary time, yet it has reached relatively high frequencies in Europe but very low among black Africans. These properties indicate that the mutation has been under intense pressure selection.
When HIV was initially discovered as the causative agent of AIDS, many expected a vaccine within a few years.
This has however proven to be elusive; it has been more than 30 years since HIV was first discovered, and a suitable vaccine is still not in effect. In 2009, a paper published by Hutter et al [5] reported on a bone marrow transplant performed on an HIV positive individual using stem J. Appl. Virol. cells that were derived from a donor who was homozygous for a mutation in the CCR5 gene known as CCR5 delta-32 [5] .
The HIV positive individual became HIV negative and remained free of viral detection after transplantation despite having stopped ART [5] .
The CCR5∆32 allele probably originated which was responsible for reduction of the population size [3] . The allele is the most [6] [7] [8] .
To 
Method
This article was a critical review of published articles sourced through extensive internet search using PubMed and Scopus using these words "CCR5
coreceptor", "evolution and distribution of CCR5∆32", "significance of CCR5∆32 in HIV science" and CCR5∆32 in Africa.
For summary of results obtained from internet search, see table 1.
Inclusion criterion
Studies findings that strictly related to CCR5 chemokine coreceptor and CCR5
∆32 mutation in HIV pathogenesis were used for this study.
Exclusion Criterion
Any study finding that was outside the scope of this topic was excluded. [9] )
Review and Discussion
The CCR5 gene produces the CCR5 chemokine coreceptor, this alongside CD4+ receptor serve as entry port for HIV into host cells. HIV attaches to the CD4 receptor through gp120 thereafter, triggers a conformational changes in virus structure which reveals its gp41 and thus binds CCR5
(figure 2). Binding brings virus in close contact with host cell surface. Subsequently, pores are formed on host cell surface as a result of binding. The HIV fuses and then enters cell [9] . During early phase of infection, HIV infects macrophages using the CCR5 coreceptor, thus they are said to and X4 strains [9, 10] .
In general, R5 strains seem to be more efficiently transmitted than X4 strains.
The predominance of R5 strains during acute HIV infection is independent from the route of HIV transmission [11, 12] .
Individuals who do not express functional CCR5 coreceptors because of a mutation in the CCR5-encoding gene are largely protected from HIV-1 infection despite the presence of functional CXCR4 coreceptors [13] . Many mechanisms have been postulated to explain the preferential transmission of R5 strains.
These include barriers at mucosal sites which may select against X4 strains but also specific humoral and cellular immune responses which may inhibit viral replication of X4 strains more effectively [14] . In 2006, it was postulated that the preferential transmission of R5 strains depends on the superimposition of multiple mechanisms rather than of one crucial 'gatekeeper' mechanism [15] . It should be recognized even in 17.2 % of the patients [16] .
In individuals infected with HIV, the percentage of CD4+ CCR5+ T-cells is higher (13.2%) than when compared to uninfected individuals (6.2%) [17] . [17] .
In 1999, a study conducted by Husman et al [18] [18] .
The CCR5Δ32 mutation
The CCR5Δ32 mutation was initially discovered in 1996 as a genetic mutation that confers protection to cells from infection by HIV [19] . Genetic analysis of the mutant gene by Liu et al revealed a deletion of 32 base pairs consisting of nucleotides [20] . amino acid wild type CCR5 [20] .
This allele has received much attention due to the fact that individuals homozygous for this mutation are resistant to infection by the HIV virus while those heterozygous for this allele who is HIV-positive have a delayed onset to AIDS of 2-3 years.
Homozygosity of CCR5∆32 in Caucasians was measured to be about 1%, with heterozygosity being anything up to 20% [21] .
Evolution of CCR5Δ32 allele
The origin of the CCR5Δ32 allele was dated back to between 2000 and 3000 years ago, as a unique mutation that increased over the years due to a selective pressure.
Stephens et al [22] used haplotype analysis on the chromosomes of 192 Caucasian individuals and estimated the origin using a coalescence theory. They hypothesized that the Black plague was the strong selective pressure that caused the mutant allele boom.
Historical data however suggest that the Black plague is not the selective force [23, 24] . The distribution of CCR5Δ32 in a north to south gradient (figure 3) does not correspond to casualties of the plague.In fact, the distribution follows a south to north gradient [25] . Moreover, the Black plague showed the greatest casualties and effects in areas with the lowest allele frequencies of CCR5Δ32, such as the Mediterranean region and China. In 2004, Mecsas et al [26] infected CCR5 deficient mice with the bacterial pathogen known to cause the evidence. The CCR5Δ32 allele frequency found in these remains was similar to that found in individuals ridden by the plague in the same region [27] . Smallpox was another pandemic hypothesized to be responsible for the CCR5Δ32 allele [28] . The pandemic had severe casualties that exceeded those of the plague. Smallpox is a virus similar to HIV, as they are known to infect lymphocytes using chemokine receptors. Conversely, historical evidence refutes this theory as smallpox started outside Europe and did not affect anyone country more significantly than another [24, 28] . The discovery of ancient DNA with similar allele frequencies of CCR5Δ32 indicated that historic pandemics such as the plague and smallpox did not result in the allele increase. and has a north to south latitude decline in frequency ( figure 3 ). Martinson et al [29] analyzed the distribution of the CCR5Δ32 mutation in more than 3000 individuals from various countries and found 2-5% gene frequencies in Middle East and some parts of the Indian subcontinent. Isolated incidences of CCR5Δ32 found in other regions were attributed to European gene flows into these areas. The highest frequency of the mutation was discovered in the Ashkenazi Jewish population at frequencies of 20.93% [3] .
In 2005, Novembre et al [3] confirmed these results when they assessed the CCR5Δ32 frequency in various population groups worldwide [3] . The mutant allele is absent in native black populations except the African American group whom might have acquired the mutation through admixture [2, 19] . Sub-Saharan Africa has been hardest hit by HIV/AIDS with more than 15% of the general population HIV-positive in some countries [30] . In comparison, heterosexual epidemics in developed countries have not reached such severe levels. Factors contributing to the severity of the epidemic in economically developing countries include economic, health, and social differences such as high levels of sexually transmitted diseases and a lack of prevention programs. However, the overwhelming rate at which the epidemic has spread in sub-Saharan Africa has not been adequately explained [31] . The rate and severity of this epidemic also could indicate a greater underlying susceptibility to HIV attributable not only to sexually transmitted disease, economics, etc., but also to other more ubiquitous factors such as host genetics [32] . To exemplify the contribution of such a host genetic factor to HIV prevalence trends in Africa, we consider the well-characterized 32-bp deletion in the host-cell chemokine receptor CCR5 i.e.
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CCR5Δ32.
It is known that following infection with HIV, the rate of clinical disease progression varies between individuals. Factors such as host susceptibility, genetics and immune function [33, 34] , health care and co-infections, as well as viral genetic variability [35] , may affect the rate of [36] .
Other researchers have focused on human leukocyte antigen as another factor [37] . All 
